Jagdeep Sabharwal, MD
Cardiovascular Disease · Appleton, WINPI 1871518282
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,907 of the $6,004 with a category attached, or 65.1%. 19 manufacturers reported payments, led by Abbott at 26.2% of the total.
Across 96 payments — averaging $62.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Edwards Lifesciences$1K
- Boston Scientific$711
- Philips North America LLC$368
- Abiomed$317
- Medtronic$252
- plus $1K from 13 others
Across 19 payments — averaging $3031.79 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- American Regent$41K
- CSL Behring$16K
What the payments were for
- Travel & lodging$2,09735%
- Food & beverage$3,90765%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 14 | $1,571 |
| Edwards Lifesciences | 10 | $1,473 |
| Boston Scientific | 13 | $711 |
| Philips North America LLC | 2 | $368 |
| Abiomed | 10 | $317 |
| Medtronic(2 entities) | 8 | $252 |
| Inari Medical, Inc. | 2 | $225 |
| Cardiovascular Systems Inc. | 16 | $167 |
| Atricure, Inc. | 1 | $146 |
| AstraZeneca | 2 | $134 |
| Boehringer Ingelheim | 2 | $127 |
| Johnson & Johnson | 2 | $119 |
| Novartis | 1 | $116 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $93 |
| W. L. Gore & Associates, Inc. | 1 | $69 |
| Pfizer | 2 | $42 |
| Chiesi USA, Inc. | 2 | $38 |
| Biotronik Inc. | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MitraClip$961
- Edwards SAPIEN 3 Transcatheter Heart Valve$583
- SAPIEN 3 Ultra RESILIA$519
- (9520) IGT Devices Undivided$368
- SYNERGY ABLATION SYSTEM$146
- FLOWTRIEVER CATHETER, S$129
- CT THROMBECTOMY SYSTEM KIT$129
- Mitra Clip system$126
- Impella$125
- Watchman$123
- LOKELMA$121
- JARDIANCE$117
- COREVALVE EVOLUT R$116
- ROTABLATOR$116
- LEQVIO$116
- Emboshield NAV6 system$103
How this compares
$6,004 in reported general payments places this provider in the 80th percentile of 322 cardiovascular disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 160 | $128,345 |
| BrilintaTicagrelor | 36 | $24,179 |
| Metoprolol Succinate | 193 | $2,111 |
| ClopidogrelClopidogrel Bisulfate | 196 | $1,944 |
| Atorvastatin Calcium | 96 | $1,177 |
| Ranolazine ErRanolazine | 19 | $830 |
| Rosuvastatin Calcium | 83 | $813 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 98 | $725 |
| Losartan Potassium | 81 | $703 |
| Potassium Chloride | 27 | $617 |
| Carvedilol | 55 | $591 |
| Ezetimibe | 27 | $554 |
| Amiodarone Hcl | 44 | $416 |
| Metoprolol Tartrate | 40 | $352 |
| Amlodipine Besylate | 50 | $309 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $42 | $128,345160 claims |
| AstraZenecaBrilinta | $134 | $24,17936 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 322 cardiovascular disease providers in Wisconsin.
Other cardiovascular disease in Appleton
- Oleg ChebotarevAppleton$22K
- Kevin ChenAppleton$20K
- Ameer KabourAppleton$16K
- Abdulmohsin AhmadjeeAppleton$15K
- Agei EnohAppleton$9K
- Richard Santa CruzAppleton$9K
- Dong Bo YuAppleton$7K
- Subhashish AgarwalBrookfield$378K
- Lee BibloMilwaukee$280K
- David GrambowMilwaukee$267K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.